Featured Abstracts
Review key findings and research highlights presented at major industry conferences and events.
Featured Content
ESTRO 2026
Preoperative radiotherapy in a single fraction for early stage breast cancer: the CRYSTAL phase I/II study update (AIRC IG-23118)
ESTRO 2026
Initial clinical experience of RayStation-based online adaptive RT using Radixact for endometrial cancer.
ESTRO 2026
One-year cumulative toxicity in 25 prostate cancer patients treated with single fraction (24 Gy) urethra-sparing radiosurgery (PRO-FAST NCT05936736 )
Featured Case Studies
Robotic Stereotactic Body Radiation Therapy For High-risk Prostate Cancer: The Georgetown University Experience
This retrospective study examines cancer control and health-related quality of life (HRQOL) outcomes in high-risk prostate cancer patients receiving robotic stereotactic body radiation therapy (SBRT) with Synchrony® real-time adaptive motion management.
Use of Motion Management to Model Unmanaged Motion: Dosimetric Consequences of Unmanaged Prostate Motion Assessed Using Real-time Radiotherapy Adaptation Data
This case report explores the dosimetric impact of unmanaged intrafraction prostate motion during radiotherapy by retrospectively analyzing real-time motion data collected using the Radixact® System with Synchrony®. The study models what would have happened if a patient had been treated without motion management, using deformation vector fields to simulate dose
Stereotactic Body Radiotherapy of a Lung Tumor with Large Respiratory Motion Using Real-time Adaptive Motion Management: A Case Report
Traditional internal target volume (ITV) methods for the treatment of a lung tumor on conventional linac would require a large planning target volume (PTV), risking high radiation exposure to the chest wall and lungs.
Urinary Quality of Life in Patients Treated with Prostate SBRT with Intra-Prostatic Boost
Nisha Bhargava et al. | ASTRO 2024
Obliteration Rates for High-Risk Arteriovenous Malformations with Dose-Escalated Hypofractionated Radiosurgery
Sophia Shah et al. |ASTRO 2024
Phase II Trial of TMLI 20 Gy in Combination with Cyclophosphamide and Etoposide in Patients with Poor-Risk Acute Leukemia
Jeffrey Wong et al. | ASTRO 2024
Commission Test of S7 Mode Stereotactic Radiosurgery CyberKnife System with Multileaf Collimator Based on AAPM MPPG.5a Guide
Pang Tingtian et al. | ASTRO 2024
